IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,239,825 | +4.2% | 3,239,000 | +6.7% | 0.24% | +0.4% |
| Q2 2023 | $3,108,087 | +6.2% | 3,037,000 | +3.5% | 0.24% | +9.0% |
| Q1 2023 | $2,926,917 | -16.0% | 2,935,000 | -8.7% | 0.22% | +2.3% |
| Q4 2022 | $3,485,101 | +7.1% | 3,213,000 | +0.2% | 0.22% | +19.2% |
| Q3 2022 | $3,255,000 | -14.1% | 3,206,000 | -9.6% | 0.18% | -20.5% |
| Q2 2022 | $3,789,000 | -32.9% | 3,548,000 | -26.8% | 0.23% | -67.8% |
| Q1 2022 | $5,643,000 | +6.6% | 4,844,000 | +4.6% | 0.71% | +97.8% |
| Q4 2021 | $5,292,000 | -10.4% | 4,633,000 | -5.1% | 0.36% | -20.4% |
| Q3 2021 | $5,903,000 | +1.2% | 4,884,000 | +0.9% | 0.45% | -14.9% |
| Q2 2021 | $5,831,000 | +25.1% | 4,839,000 | +18.6% | 0.53% | -2.4% |
| Q1 2021 | $4,662,000 | +8.2% | 4,079,000 | +7.1% | 0.54% | +21.2% |
| Q4 2020 | $4,308,000 | +27.1% | 3,808,000 | +10.7% | 0.45% | +12.0% |
| Q3 2020 | $3,390,000 | – | 3,441,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 35,225,000 | $39,760,000 | 1.94% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,079,000 | $4,662,000 | 0.54% |
| AQR Arbitrage LLC | 11,500,000 | $13,038,000 | 0.47% |
| Context Capital Management, LLC | 3,934 | $4,460,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,938,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,748,000 | 0.06% |
| LINDEN ADVISORS LP | 6,201,000 | $7,007,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 14,500,000 | $16,439,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $77,681,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,976,000 | $9,002,000 | 0.02% |